| CG Oncology, Inc. | 1.89M | US$134M | 26.1% |
| Tango Therapeutics, Inc. | 2.23M | US$55.7M | 10.9% |
| Revolution Medicines, Inc. | 265K | US$54.3M | 10.6% |
| Liquidia Corporation | 596K | US$18M | 3.5% |
| ArriVent BioPharma, Inc. | 451K | US$13.7M | 2.7% |
| Enliven Therapeutics, Inc. | 262K | US$12M | 2.3% |
| Avalo Therapeutics, Inc. | 773K | US$11.8M | 2.3% |
| Xencor, Inc. | 445K | US$11.1M | 2.2% |
| Roivant Sciences Ltd. | 290K | US$10.6M | 2.1% |
| Abivax SA | 99,274 | US$9.83M | 1.9% |
| Assembly Biosciences, Inc. | 417K | US$9.81M | 1.9% |
| Veradermics, Incorporated | 80,000 | US$9.7M | 1.9% |
| Protagonist Therapeutics, Inc. | 45,659 | US$6.43M | 1.3% |
| Century Therapeutics, Inc. | 4.42M | US$6.08M | 1.2% |
| Eupraxia Pharmaceuticals, Inc. | 572K | US$5.21M | 1.0% |
| Axsome Therapeutics, Inc. | 24,066 | US$4.44M | 0.87% |
| Sagimet Biosciences Inc. - Series A | 429K | US$4.24M | 0.83% |
| Zentalis Pharmaceuticals, Inc. | 1.5M | US$4.17M | 0.81% |
| Definium Therapeutics, Inc. | 109K | US$4.14M | 0.81% |
| Dianthus Therapeutics, Inc. | 46,432 | US$4.09M | 0.80% |
| Silence Therapeutics PLC | 350K | US$3.83M | 0.75% |
| Tarsus Pharmaceuticals, Inc. | 48,530 | US$3.81M | 0.75% |
| Immunic, Inc. | 687K | US$3.66M | 0.72% |
| Taysha Gene Therapies, Inc. | 750K | US$3.65M | 0.71% |
| Cytokinetics, Incorporated | 53,748 | US$3.54M | 0.69% |
| Minerva Neurosciences, Inc | 1M | US$3.35M | 0.66% |
| Relay Therapeutics, Inc. | 186K | US$3.35M | 0.66% |
| Zai Lab Ltd. | 118K | US$3.12M | 0.61% |
| Praxis Precision Medicines, Inc. | 10,489 | US$3.05M | 0.60% |
| CytomX Therapeutics, Inc. | 1.09M | US$2.95M | 0.58% |
| Editas Medicine, Inc. | 1.92M | US$2.94M | 0.58% |
| SAB Biotherapeutics, Inc. | 753K | US$2.39M | 0.47% |
| Adlai Nortye Group Ltd. | 116K | US$1.86M | 0.36% |
| Sutro Biopharma, Inc. | 99,894 | US$1.61M | 0.31% |
| United Therapeutics Corporation | 2,940 | US$1.59M | 0.31% |
| Inventiva SA | 414K | US$1.53M | 0.30% |
| Harmony Biosciences Holdings, Inc. | 37,900 | US$1.49M | 0.29% |
| AN2 Therapeutics, Inc. | 254K | US$1.35M | 0.26% |
| Celldex Therapeutics, Inc. | 40,868 | US$1.32M | 0.26% |
| Summit Therapeutics Inc. | 76,648 | US$1.3M | 0.25% |
| Vaxcyte, Inc. | 22,066 | US$1.26M | 0.25% |
| TCGX Acquisition Corp. | 100K | US$1.25M | 0.24% |
| Contineum Therapeutics, Inc. | 86,654 | US$1.16M | 0.23% |
| Biohaven Ltd. | 81,221 | US$1.08M | 0.21% |
| Spyre Therapeutics, Inc. | 11,611 | US$1.03M | 0.20% |
| InMed Pharmaceuticals Inc. | 1.07M | US$1M | 0.20% |
| Corvus Pharmaceuticals, Inc. | 84,590 | US$974K | 0.19% |
| Perspective Therapeutics, Inc. | 296K | US$814K | 0.16% |
| Inhibikase Therapeutics, Inc. | 358K | US$737K | 0.14% |
| OnKure Therapeutics, Inc. | 241K | US$657K | 0.13% |
| Cogent Biosciences, Inc. | 19,326 | US$619K | 0.12% |
| LeonaBio, Inc. | 158K | US$565K | 0.11% |
| Amylyx Pharmaceuticals, Inc. | 18,558 | US$540K | 0.11% |
| Lisata Therapeutics, Inc. | 371K | US$535K | 0.10% |
| Erasca, Inc. | 34,976 | US$513K | 0.10% |
| C4 Therapeutics, Inc. | 140K | US$466K | 0.09% |
| Avalyn Pharma Inc. | 14,710 | US$419K | 0.08% |
| Neurogene Inc. | 14,700 | US$409K | 0.08% |
| MBX Biosciences, Inc. | 6,810 | US$399K | 0.08% |
| Beam Therapeutics Inc. | 15,844 | US$387K | 0.08% |
| Palisade Bio, Inc. | 272K | US$367K | 0.07% |
| Bright Minds Biosciences Inc. | 6,395 | US$319K | 0.06% |
| Geron Corporation | 259K | US$318K | 0.06% |
| Obsidian Therapeutics, Inc. | 23,077 | US$317K | 0.06% |
| IDEAYA Biosciences, Inc. | 7,950 | US$305K | 0.06% |
| Sensei Biotherapeutics, Inc. | 10,204 | US$303K | 0.06% |
| Tectonic Therapeutic, Inc. | 12,000 | US$279K | 0.05% |
| Disc Medicine, Inc. | 4,100 | US$268K | 0.05% |
| Abeona Therapeutics Inc. | 48,745 | US$256K | 0.05% |
| Unicycive Therapeutics, Inc. | 51,700 | US$243K | 0.05% |
| Aclaris Therapeutics, Inc. | 44,200 | US$232K | 0.05% |
| Compass Therapeutics, Inc. | 193K | US$201K | 0.04% |
| Inovio Pharmaceuticals, Inc. | 137K | US$167K | 0.03% |
| ProMIS Neurosciences Inc. | 10,600 | US$115K | 0.02% |
| Lipocine Inc. | 34,161 | US$75,154 | 0.01% |
| Opus Genetics, Inc. | 10,000 | US$48,400 | <0.01% |
| Processa Pharmaceuticals, Inc. | 18,300 | US$30,012 | <0.01% |
| Fulcrum Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Krystal Biotech, Inc. | 0 | US$0 | 0.00% |
| Larimar Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Madrigal Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Milestone Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Mirum Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Monte Rosa Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Olema Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| PMV Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Relmada Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Savara, Inc. | 0 | US$0 | 0.00% |
| Stoke Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Syndax Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Trevi Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Viking Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Voyager Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Xenon Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Agios Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| BioCryst Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Celcuity Inc. | 0 | US$0 | 0.00% |
| Corbus Pharmaceuticals Holdings, Inc. | 0 | US$0 | 0.00% |
| Cue Biopharma, Inc. | 0 | US$0 | 0.00% |
| Damora Therapeutics, Inc. | 0 | US$0 | 0.00% |